Mitsubishi Pharma Europe Ltd was established in 2001 with headquarters based in London. On 1st June 2014, the company name changed to Mitsubishi Tanabe Pharma Europe Ltd (MTPE) in order to unify the company name with that of our parent company, Mitsubishi Tanabe Pharma Corporation (MTPC). We also have business operations in Germany, Austria and Switzerland, our subsidiary company, Mitsubishi Tanabe Pharma GmbH, is responsible for the distribution, sales and marketing activities in the German, Austrian and Swiss territories. We are engaged in the management of clinical research and commercial operations on behalf of Mitsubishi Tanabe Pharma Corporation, in the European Union (EU) and other related European territories.
View Top Employees from Mitsubishi Tanabe Pharma CorporationWebsite | http://www.mt-pharma-eu.com |
Revenue | $18 million |
Employees | 336 (204 on RocketReach) |
Founded | 2001 |
Address | 525 Washington Blvd, Jersey City, New Jersey 07310, US |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
Web Rank | 14 Million |
Keywords | Pharmaceutical Products, Clinical Research, Drug Development And Manufacturing, Sales And Marketing, Pharmaceutical Research, Clinical Trials, Healthcare Products, Medical Products |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Mitsubishi Tanabe Pharma Corporation employee's phone or email?
The Mitsubishi Tanabe Pharma Corporation annual revenue was $18 million in 2024.
Kazutaka Maeda is the Managing Director and Vice President of Mitsubishi Tanabe Pharma Corporation.
204 people are employed at Mitsubishi Tanabe Pharma Corporation.
Mitsubishi Tanabe Pharma Corporation is based in Jersey City, New Jersey.
The NAICS codes for Mitsubishi Tanabe Pharma Corporation are [325, 32, 3254, 32541].
The SIC codes for Mitsubishi Tanabe Pharma Corporation are [283, 28].